Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Ther... by Chieko Michikawa, DDS, PhD, Pedro A. Torres-Saavedra, PhD, Natalie L. Silver, MD, MS, Paul M. Harari, MD, Merrill S. Kies, MD, David I. Rosenthal, MD, Quynh-Thu Le, MD, Richard C. Jordan, DDS, PhD, Dzifa Y. Duose, PhD, Saradhi Mallampati, DVM, PhD, Sanchit Trivedi, MS, Rajyalakshmi Luthra, PhD, Ignacio I. Wistuba, MD, Abdullah A. Osman, PhD, Olivier Lichtarge, MD, PhD, Robert L. Foote, MD, Upendra Parvathaneni, MBBS, D. Neil Hayes, MD, MPH, Curtis R. Pickering, PhD, Jeffrey N. Myers, MD, PhD

Get full text